Signing of Memorandum of Understanding (MoU), 18th August, 2022:
The signing of the MoU between CELLINK and the Indian Institute of Science (IISc) marks a significant milestone in the establishment of the Centre of Excellence (CoE) for 3D bioprinting. This formal agreement solidifies the partnership between the two organizations and sets the foundation for collaboration in advancing research in tissue engineering, regenerative medicine, and drug discovery. The MoU highlights the shared commitment to leveraging cutting-edge technologies and expertise to drive innovation and improve health outcomes.
Inauguration of the CoE, 9th December, 2022
The inauguration of the CoE for 3D bioprinting marks another significant milestone in the advancement of advanced bioprinting capabilities in India. The event was attended by key dignitaries, including government officials, industry experts, and academic leaders. It symbolizes the recognition of the CoE as a premier hub for bioprinting research and innovation. With state-of-the-art bioprinting technologies, the CoE aims to facilitate groundbreaking research, provide access to cutting-edge equipment, and foster collaboration among researchers, ultimately leading to advancements in tissue engineering, personalized medicine, and other critical fields.